¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"adrenergic blocking agent"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¼³¸í
adrenergic blocking agent
¾Æµå·¹³¯¸° Â÷´ÜÁ¦
¾Æµå·¹³¯¸°¼º ¼ö¿ëü¿¡ ÀÛ¿ëÇÏ¿© ½Å°æ Àü´Þü¿Í ¼ö¿ëü°¡ °áÇÕÇÏÁö ¸øÇÏ°Ô ÇÔÀ¸·Î½á ±³°¨½Å°æ ÈïºÐ È¿°ú¸¦ ºÀ¼âÇÏ´Â ¾à¹°.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¼³¸í
beta-adrenergic blocking agent
º£Å¸ ¾Æµå·¹³¯¸°¼º Â÷´ÜÁ¦
autonomic blocking agent
ÀÚÀ² ½Å°æ Â÷´ÜÁ¦
cholinergic blocking agent
Ç×Äݸ°¾à, Äݸ°¼º Â÷´ÜÁ¦
neuromuscular blocking agent
½Å°æ±Ù Â÷´ÜÁ¦, ½Å°æ±Ù Â÷´Ü ¾à
receptor blocking agent
¼ö¿ëü Â÷´ÜÁ¦
sympathetic blocking agent
±³°¨½Å°æ ºÀ¼âÁ¦, ±³°¨½Å°æ Â÷´ÜÁ¦
2-adrenergic agonist
2-¾Æµå·¹³¯¸° ÀÛ¿ëÁ¦, 2-¾Æµå·¹³¯¸° ÀÛµ¿Á¦
adrenergic agonist
¾Æµå·¹³¯¸°¼º ÀÛµ¿¾à
¾Æµå·¹³¯¸°¼º ¼ö¿ëü¸¦ ÈïºÐ½ÃÅ´À¸·Î½á È¿°ú¸¦ ³ªÅ¸³»´Â ¾à¹°. ´ë°Ô ¾Æ¹Î ÈÇÕ¹°À̹ǷΠ±³°¨½Å°æ À¯»ç ¾Æ¹ÎÀ̶ó°íµµ ÇÑ´Ù.
adrenergic fiber
¾Æµå·¹³¯¸°¼º ¼¶À¯
adrenergic neurotransmitter
¾Æµå·¹³¯¸°¼º ½Å°æ Àü´Þ ¹°Áú
adrenergic stimulating drug
¾Æµå·¹³¯¸° ÈïºÐ ¾à, ¾Æµå·¹³¯¸°¼º ÈïºÐ¾à, ¾Æµå·¹³¯¸° ÀÚ±ØÁ¦, ¾Æµå·¹³¯¸°¼º ÀÚ±ØÁ¦
adrenergic transmission
¾Æµå·¹³¯¸°¼º Àü´Þ
³ë¸£¾Æµå·¹³¯¸° ¶Ç´Â ¾Æµå·¹³¯¸°À» Àü´Þ ¹°Áú·Î ÇÏ´Â ÈïºÐ Àü´Þ. ±³°¨½Å°æÀÇ ¹ß´ÜÀ» °ÅÀÇ À̰ÍÀÌ´Ù. ±³°¨ ½Å°æ ¼¶À¯°¡ ÈïºÐÇÏ¸é ¸»´Ü¿¡¼ ³ë¸£¾Æµå·¹³¯¸° µîÀÌ ¹æÃâµÇ°í À̰ÍÀÌ È¿°ú±âÀÇ ¼ö¿ë±â¿¡ µµ´ÞÇØ ÈïºÐµÈ´Ù. ÈïºÐ
adrenergic urticaria
¾Æµå·¹³¯¸°¼º µÎµå·¯±â
alpha 1-adrenergic blocker
¾ËÆÄ 1-¾Æµå·¹³¯¸°¼º Â÷´Ü
alpha adrenergic antagonist
¾ËÆÄ ¾Æµå·¹³¯¸° ±æÇ×Á¦
´ÙÀ½
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½